Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now small index

Anxiety Disorders and Symptoms clinical trials

5 of 10 indexed Anxiety Disorders and Symptoms trials are currently recruiting.

Corpus placement: #1,724 of 28,707 conditions by registered trial count.

10 US clinical trials · 5 currently recruiting · #1,724 of 28,707 conditions by registered trial count

Anxiety Disorders and Symptoms: 10 US clinical trials tracked, 5 recruiting.

Anxiety Disorders and Symptoms is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. The most active sponsor is Weill Medical College of Cornell University, running 3 of these trials.

Enrollment posture brief

Registry condition anxiety-disorders-and-symptoms

OPEN 5 | RECR 50% | LATE 0 | EARLY 0 | RANK #1724 | SPON 3

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Acute Leukemia of Ambiguous 80%Anxiety Disorders and Sy (th…50%Achondroplasia40%Accelerated Phase Chronic My20%Accidental Fall20%
Open-enrollment share among volume-matched conditions near Anxiety Disorders and Symptoms

Anxiety Disorders and Symptoms lists 5 open slots (50% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Anxiety Disorders and Symptoms on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Anxiety Disorders and Symptoms is recruiting above its size-band peers.

    5 of 10 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Anxiety Disorders and Symptoms research.

    Weill Medical College of Cornell University accounts for 3 of 10 trials (30%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Most Anxiety Disorders and Symptoms trials plan to enrol fewer than 100 people.

    Median target enrolment is 82 among the 10 trials that report a genuine target (sentinel values excluded). 6 of those (60%) plan for fewer than 100 participants.

  4. Anxiety Disorders and Symptoms research is mostly interventional.

    9 interventional and 1 observational studies make up this index (90% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Anxiety Disorders and Symptoms records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Positive Valence System Treatment Behavioral
1 trials
Stress Management Training (6 Sessions) Behavioral
1 trials
Amplification of Positivity Training (6 Sessions) Behavioral
1 trials
Loss Framed Behavioral
1 trials
Gain Framed Behavioral
1 trials
Maya mobile app Behavioral
1 trials
Appa Lite Behavioral
1 trials
Appa Complete Behavioral
1 trials

US sites by state

Facility locations filed on Anxiety Disorders and Symptoms trials. A trial with sites in several states counts in each.

New York 3 trials
California 3 trials
New Mexico 1 trials
New Jersey 1 trials
Michigan 1 trials
Georgia 1 trials
Delaware 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Anxiety Disorders and Symptoms page

10 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Anxiety Disorders and Symptoms condition card totals 10 registered trials; most-linked intervention Positive Valence System Treatment; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.